Carregant...
Tumor mutation burden (TMB)-associated signature constructed to predict survival of lung squamous cell carcinoma patients
Lung squamous cell carcinoma (LUSC) is a common type of lung cancer with high incidence and mortality rate. Tumor mutational burden (TMB) is an emerging biomarker for selecting patients with non-small cell lung cancer (NSCLC) for immunotherapy. This study aimed to reveal TMB involved in the mechanis...
Guardat en:
| Publicat a: | Sci Rep |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group UK
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8079676/ https://ncbi.nlm.nih.gov/pubmed/33907270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-88694-7 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|